Systemic ALK-negative ALCL, on the other hand, typically affects older individuals and lacks ALK gene rearrangement, leading to a less favorable prognosis with a five-year survival rate of around 40-60% [3]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.